Radiotherapy Positioning Devices Market Segmentation by Product Type (Head, Neck, & Brain Immobilization Device, Thorax & Breast Immobilization Device, Pelvic Immobilization Devices, and Others); and by End-Users (Hospitals, Cancer Research Institutes, Ambulatory Surgical Centers, and Others)-Global Demand Analysis & Opportunity Outlook 2020-2030
-
Product Code:
RP-ID-10352281 -
Published Date:
2 Nov 2022 -
Region:
Global
-
Pages:
137 -
Category:
Healthcare & Pharmaceuticals -
Publisher:
Pub-ID-54
Impact Analysis on the Growth of Market
Inflation and Looming Recession to Haunt Businesses:
In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.
....
The Research Report is Updated with 2022 Base Year, 2023 Estimated year and Forecast till 2035 with Market Insights.
With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2022 as base year, 2023 as estimated year and forecast to 2035. This will have market drivers, recovery rate in the market, insights and competitive analysis.
Market Overview:
Translate Report
Global Radiotherapy Positioning Devices Market Highlights Over 2020 - 2030
The global radiotherapy positioning devices market is estimated to garner a revenue of USD 371.47 Million by the end of 2030 by growing at a CAGR of 8.01% over the forecast period, i.e., 2021 – 2030. Moreover, the market registered a revenue of USD 172.87 Million in the year 2020. The growth of the market can be attributed to growing advancements in healthcare, backed by the rising healthcare expenditure, along with the growing incidences of cancer globally. Cancer, which is one of the leading causes of death around the globe, accounted for around 10 Million deaths in the year 2020, according to statistics by the World Health Organization (WHO). Moreover, among the most common causes of cancer deaths in the year 2020 was due to lung cancer which recorded 1.80 Million deaths in the same year. It was followed by colon & rectum cancer with 935000 deaths and liver cancer with 830000 deaths. Radiotherapy helps to damage the genetic material of the cancer cells. With the growing incidences of cancer, and the surge in the need for radiotherapy, the demand for radiotherapy positioning devices is projected to increase, and in turn, accelerate the growth of the market in the coming years.
Besides this, the growing government initiatives that are aimed to provide healthcare support to citizens, along with the increasing number of hospitals and the rising number of inpatients in hospitals for cancer treatment, are also expected to drive market growth in the coming years.
CLICK TO DOWNLOAD A SAMPLE REPORT
Global Radiotherapy Positioning Devices Market Regional Synopsis
Regionally, the global radiotherapy positioning devices market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in North America is projected to garner the largest revenue of USD 130.57 Million by the end of 2030, up from a revenue of USD 61.13 Million in the year 2020. The growth of the market in the region can primarily be attributed to the growing healthcare expenditure in the region, followed by the presence of a strong healthcare network, especially in the United States. According to the statistics by the World Bank, the current health expenditure as a share of GDP in the United States grew from 15.286% in the year 2008 to 16.885% in the year 2018. On the other hand, the market in Europe is anticipated to garner the second-largest revenue of USD 118.91 Million by the end of 2030, up from a revenue of USD 56.72 Million in the year 2020. The market in the region is further segmented by country into the United Kingdom, Germany, Italy, France, Spain, Russia, Netherlands, and the Rest of Europe. Out of these, the market in Germany is projected to garner the largest revenue of USD 26.96 Million by the end of 2030, up from a revenue of USD 12.36 Million in the year 2020.
Growth Drivers and Challenges Impacting the Growth of the Global Radiotherapy Positioning Devices Market
Growth Drivers
-
Growing Incidences of Cancer
-
Rising Government Initiatives to Provide Healthcare Support to Citizens
-
Increasing Healthcare Expenditure
Challenges
-
Limited Access to Advanced Healthcare Systems in Several Developing and Under-Developed Countries
Global Radiotherapy Positioning Devices Market Segmentation Synopsis
The global radiotherapy positioning devices market is segmented by product type into head, neck & brain immobilization devices, thorax & breast immobilization devices, pelvic immobilization devices, and others. Out of these, the thorax & breast immobilization device segment is anticipated to garner the largest revenue of USD 125.92 Million by the end of 2030, up from a revenue of USD 59.11 Million in the year 2020. By end-user, the market is segmented into hospitals, cancer research institutes, ambulatory surgical centers, and others. Out of these, the hospital's segment is projected to garner the largest revenue of USD 221.16 Million by the end of 2030, up from a revenue of USD 101.20 Million in the year 2020.
Key Companies Dominating the Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global radiotherapy positioning devices market that are included in our report are C-RAD, CIVCO Radiotherapy, Elekta AB, BIONIX LLC, ORFIT INDUSTRIES NV, Qfix, Klarity Medical Products, IZI Medical Products, CDR Systems, Candor ApS, and others.
Latest Developments in the Global Radiotherapy Positioning Devices Market:
-
December 4th, 2020: BIONIX LLC announced the launch of SecureFoam Pouch-Pro, a custom patient positioning single-patient use product, to help hospitals and healthcare facilities reduce the risk of cross-contamination of coronavirus, the virus causing COVID-19.
-
October 24th, 2021: Qfix announced the launch of the Encompass 15-Channel Head Coil, a positioning product specifically designed to accommodate the high precision positioning that is unique to the Encompass MR SRS Immobilization System and with select Siemens 3T MRI Systems.
Key Reasons to Buy Our Report
-
The report covers a detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis, and challenges that impact market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessments for overall growth.
-
We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
Geography Analysis:
The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:
- North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys & Opportunity Outlook
- Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook
.
FREQUENTLY ASKED QUESTIONS
The growing incidences of cancer, rising government initiatives to provide healthcare support to citizens, along with the increasing healthcare expenditure are some of the major factors expected to drive the market growth.
The market is anticipated to attain a CAGR of 8.01% over the forecast period, i.e., 2021-2030.
The limited access to advanced healthcare systems in several developing and under-developed countries is one of the major factors estimated to hamper the market growth.
The market in North America is projected to garner the largest revenue of USD 130.57 Million by the end of 2030 and provide more business opportunities for growth in the future.
The major players in the market are C-RAD, CIVCO Radiotherapy, Elekta AB, BIONIX LLC, ORFIT INDUSTRIES NV, Qfix, Klarity Medical Products, and others.
The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by product type, end-users, and by region.
The thorax & breast immobilization device segment is anticipated to garner the largest revenue of USD 125.92 Million by the end of 2030 and display significant growth opportunities.
1. Market Definition
1.1. Definition
1.2.Market Segmentation
2. Assumptions and Acronyms
3. Research Methodology
3.1.Research Process
3.2. Primary Research
3.3. Secondary Research
4. Analyst Review
5. Executive Summar-Global Radiotherapy Positioning Devices Market
6. Market Dynamics
6.1.Market Drivers
6.2. Market Trends
7. Key Market Opportunities
8. Major Roadblocks for the Market Growth
9. Regulatory and Standards Landscape
10. Industry Risk Analysis
11. Pricing Analysis of Radiotherapy Positioning Devices Market
12.Value Chain Analysis
13.Analysis on the Key End User of Radiotherapy Positioning Devices
14.Competitive Positioning
15. Competitive Landscape
15.1. Market Share Analysis, 2020
15.2. Competitive Benchmarking
15.3. Company Profiles
15.3.1. C-RAD
15.3.2. CIVCO Radiotherapy
15.3.3. Elekta AB
15.3.4. BIONIX LLC
15.3.5. ORFIT INDUSTRIES NV
15.3.6. Qfix
15.3.7. Klarity Medical Products
15.3.8. IZI Medical Products
15.3.9. CDR Systems
15.3.10. Candor ApS
16.Global Radiotherapy Positioning Devices Market 2020-2030
16.1. Market Overview
16.2. By Value (USD Million)
17. Global Radiotherapy Positioning Devices Market-Segmentation Analysis 2020-2030
17.1. Product Type
17.1.1. Head, Neck and Brain Immobilization Device, 2020-2030F (USD Million)
17.1.2. Thorax and Breast Immobilization Device, 2020-2030F (USD Million)
17.1.3. Pelvic Immobilization Devices, 2020-2030F (USD Million)
17.1.4. Others, 2020-2030F (USD Million)
17.2. End-User
17.2.1. Hospitals, 2020-2030F (USD Million)
17.2.2. Cancer Research Institutes, 2020-2030F (USD Million)
17.2.3. Ambulatory surgical centers, 2020-2030F (USD Million)
17.2.4. Others, 2020-2030F (USD Million)
17.3. Region
17.3.1. North America
17.3.2. Europe
17.3.3. Asia Pacific
17.3.4. Latin America
17.3.5. Middle East & Africa
18.North America Radiotherapy Positioning Devices Market 2020-2030
18.1. Market Overview
18.2. Market Value (USD Million)
18.3. Market Segmentation By:
18.3.1. Product Type
18.3.1.1. Head, Neck and Brain Immobilization Device, 2020-2030F (USD Million)
18.3.1.2. Thorax and Breast Immobilization Device, 2020-2030F (USD Million)
18.3.1.3. Pelvic Immobilization Devices, 2020-2030F (USD Million)
18.3.1.4. Others, 2020-2030F (USD Million)
18.3.2. End-User
18.3.2.1. Hospitals, 2020-2030F (USD Million)
18.3.2.2. Cancer Research Institutes, 2020-2030F (USD Million)
18.3.2.3. Ambulatory surgical centers, 2020-2030F (USD Million)
18.3.2.4. Others, 2020-2030F (USD Million)
18.3.3. Country
18.3.3.1. United States
18.3.3.2. Canada
19.Europe Radiotherapy Positioning Devices Market 2020-2030
19.1. Market Overview
19.2. Market Value (USD Million)
19.3. Market Segmentation By:
19.3.1. Product Type
19.3.2. End-User
19.3.3. Country
19.3.3.1. UK
19.3.3.2. Germany
19.3.3.3. Italy
19.3.3.4. France
19.3.3.5. Spain
19.3.3.6. Russia
19.3.3.7. Netherlands
19.3.3.8. Rest of Europe
20. Asia Pacific Radiotherapy Positioning Devices Market 2020-2030
20.1. Market Overview
20.2. Market Value (USD Million)
20.3. Market Segmentation By:
20.3.1. Product Type
20.3.2. End-User
20.3.3. Country
20.3.3.1. Australia
20.3.3.2. Japan
20.3.3.3. Singapore
20.3.3.4. South Korea
20.3.3.5. India
20.3.3.6. China
20.3.3.7. Rest of Asia Pacific
21.Latin America Radiotherapy Positioning Devices Market 2020-2030
21.1. Market Overview
21.2. Market Value (USD Million)
21.3. Market Segmentation By:
21.3.1. Product Type
21.3.2. End-User
21.3.3. Country
21.3.3.1. Brazil
21.3.3.2. Mexico
21.3.3.3. Argentina
21.3.3.4. Rest of Latin America
22. Middle East & Africa Radiotherapy Positioning Devices Market 2020-2030
22.1. Market Overview
22.2. Market Value (USD Million)
22.3. Market Segmentation By:
22.3.1. Product Type
22.3.2. End-User
22.3.3. Country
22.3.3.1. GCC
22.3.3.2. Israel
22.3.3.3. South Africa
22.3.3.4. Rest of Middle East & Africa
Please enter your personal details below
- C-RAD
- CIVCO Radiotherapy
- Elekta AB
- BIONIX LLC
- ORFIT INDUSTRIES NV
- Qfix
- Klarity Medical Products
- IZI Medical Products
- CDR Systems
- Candor ApS